At a glance
ClinicalIndex Comparison RecordN/ACompleted· 491 enrolled
Drug / intervention
Implanted with a Nanostim leadless pacemaker systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Nanostim Study for a Leadless Cardiac Pacemaker System
In Brief
An observational study evaluating Implanted with a Nanostim leadless pacemaker system for Indications for VVI(R) Pacemaker. Completed, enrolled 491 participants across 32 sites in 7 countries.
Detailed Summary
The objective of the study is to confirm clinical performance and safety of the Nanostim leadless cardiac pacemaker system within its intended use and according to its instructions for use.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsIndications for VVI(R) Pacemaker
CountriesCzechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartDec 2013
First PostedJan 2014
Primary CompletionMar 2017
Study CompletionDec 2021
TodayJul 2026
First PostedJan 31, 2014
Enrollment StartDec 1, 2013
Primary CompletionMar 1, 2017
Study CompletionDec 22, 2021
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 12.4 years ago
Interventions
Implanted with a Nanostim leadless pacemaker systemdevice